by Jordana Choucair | Dec 20, 2021 | Opioid/Substance Use Disorders
A new HHS Office of the Inspector General report found that less than 16 percent of more than one million Medicare beneficiaries diagnosed with opioid use disorder in 2020 received medication to treat the condition. Furthermore, less than one third of those who...
by Jordana Choucair | Dec 20, 2021 | Life Sciences
Moderna said preliminary data shows that its COVID-19 booster provides protection against omicron, but that a double dose of the booster shot provided a much greater increase in those levels. Its currently FDA-approved 50ug booster was found to increase neutralizing...
by Jordana Choucair | Dec 20, 2021 | D.C. News
Senator Joe Manchin said he will not vote for the Build Back Better Act, effectively ending negotiations on the legislation that would expand the nation’s social safety net. Manchin has always been a key holdout on the legislation, sharing concerns over certain...
by Jordana Choucair | Dec 17, 2021 | Opioid/Substance Use Disorders
A federal court judge has reversed the Purdue Pharma bankruptcy plan. A provision in the plan grants immunity to some of the Sacklers as well as hundreds of their associates from future lawsuits, even though — unlike Purdue — they did not file for bankruptcy...
by Jordana Choucair | Dec 17, 2021 | Life Sciences
Regeneron Pharmaceuticals said its monoclonal antibody treatment for COVID-19 has “diminished potency” against the omicron variant but remains effective against delta. The drugmaker also said it is working on next-generation drugs that could protect...
Recent Comments